Treatment of the AD-tau seeded neuronal cultures with a pool of four rat APP siRNA at DIV7 led to dose-dependent decrease of APP protein in the cultures at DIV21, with 1 μM pooled APP siRNA causing ∼80% reduction of APP (not shown). Here, MAPT is linked to Alzheimer disease.